Published in J Midwifery Womens Health on December 31, 2007
Oral contraceptive use among women in the military and the general U.S. population. J Womens Health (Larchmt) (2010) 0.77
Use of Dual Methods for Protection from Unintended Pregnancy and Sexually Transmitted Diseases in Adolescent African American Women. J Pediatr Adolesc Gynecol (2015) 0.75
Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med (2013) 6.35
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study. J Clin Oncol (2007) 5.81
Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med (2014) 4.01
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev (2004) 3.80
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 3.22
A longitudinal assessment of the impact of smoke-free worksite policies on tobacco use. Am J Public Health (2005) 3.05
Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr (2009) 2.90
Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res (2004) 2.89
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.82
Do cigarette prices motivate smokers to quit? New evidence from the ITC survey. Addiction (2010) 2.68
Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tob Res (2004) 2.63
Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev (2005) 2.59
Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am J Public Health (2007) 2.52
Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract (2005) 2.51
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
Predictors of smoking relapse by duration of abstinence: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction (2009) 2.36
Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics (2003) 2.35
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2009) 2.32
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study. Clin Cancer Res (2005) 2.22
Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidism. J Pediatr (2008) 2.20
How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction (2012) 2.13
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav (2013) 2.07
Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr (2010) 2.06
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Environmental pollutants and breast cancer: epidemiologic studies. Cancer (2007) 1.99
Alcohol consumption by women before and during pregnancy. Matern Child Health J (2008) 1.94
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92
Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med (2005) 1.90
Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (2009) 1.87
Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2009) 1.82
The effect of a smoke-free law on restaurant business in South Australia. Aust N Z J Public Health (2002) 1.80
Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. J Clin Oncol (2011) 1.80
Diet and breast cancer: a review of the prospective observational studies. Cancer (2007) 1.77
Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials. J Clin Oncol (2012) 1.74
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
What do Marlboro Lights smokers know about low-tar cigarettes? Nicotine Tob Res (2004) 1.70
The role of public policies in reducing smoking prevalence in California: results from the California tobacco policy simulation model. Health Policy (2006) 1.68
Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med (2006) 1.66
How smoke-free laws improve air quality: a global study of Irish pubs. Nicotine Tob Res (2009) 1.66
An experimental investigation of tobacco smoke pollution in cars. Nicotine Tob Res (2009) 1.66
Impact of nicotine replacement therapy on smoking behavior. Annu Rev Public Health (2005) 1.65
Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. Int J Epidemiol (2004) 1.58
Residential mobility during pregnancy and the potential for ambient air pollution exposure misclassification. Environ Res (2009) 1.56
Drop-the-losers design: normal case. Biom J (2005) 1.55
Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol (2006) 1.55
Lifetime cumulative exposure to secondhand smoke and risk of myocardial infarction in never smokers: results from the Western New York health study, 1995-2001. Arch Intern Med (2006) 1.51
Early evidence on the effectiveness of clean indoor air legislation in New York State. Am J Public Health (2005) 1.50
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clin Cancer Res (2011) 1.47
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47
A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q). Gynecol Oncol (2010) 1.45
Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol (2014) 1.45
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol (2010) 1.43
Secondhand smoke and particulate matter exposure in the home. Nicotine Tob Res (2009) 1.42
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2010) 1.41
Maternal butalbital use and selected defects in the national birth defects prevention study. Headache (2013) 1.39
Environmental monitoring of secondhand smoke exposure. Tob Control (2012) 1.39
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Ann Epidemiol (2010) 1.33
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study. Gynecol Oncol (2007) 1.31
Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 1.30
Trends in the use of premium and discount cigarette brands: findings from the ITC US Surveys (2002-2011). Tob Control (2013) 1.27
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial. J Clin Oncol (2010) 1.26
Giving away free nicotine medications and a cigarette substitute (Better Quit) to promote calls to a quitline. J Public Health Manag Pract (2005) 1.25
Support and correlates of support for banning smoking in cars with children: findings from the ITC Four Country Survey. Eur J Public Health (2010) 1.24
Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer (2004) 1.24
Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood (2007) 1.23
Which population-based interventions would motivate smokers to think seriously about stopping smoking? Am J Health Promot (2004) 1.23
Predictors of smoking in cars with nonsmokers: findings from the 2007 Wave of the International Tobacco Control Four Country Survey. Nicotine Tob Res (2010) 1.23
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol (2011) 1.23
Use of less expensive cigarettes in six cities in China: findings from the International Tobacco Control (ITC) China Survey. Tob Control (2010) 1.22
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res (2011) 1.22
Alcohol consumption and quitting smoking in the International Tobacco Control (ITC) Four Country Survey. Drug Alcohol Depend (2008) 1.21
The quitting rollercoaster: how recent quitting history affects future cessation outcomes (data from the International Tobacco Control 4-country cohort study). Nicotine Tob Res (2013) 1.20
Is the prevalence of youth smoking affected by efforts to increase retailer compliance with a minors' access law? Nicotine Tob Res (2003) 1.20
Maternal low-level lead exposure and fetal growth. Environ Health Perspect (2010) 1.20
Evaluation of smoke-free dining in South Australia: support and compliance among the community and restaurateurs. Aust N Z J Public Health (2002) 1.19
Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology (2012) 1.17
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer (2011) 1.17
Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay. Tob Control (2012) 1.16
Compliance and support for bans on smoking in licensed venues in Australia: findings from the International Tobacco Control Four-Country Survey. Aust N Z J Public Health (2010) 1.14
Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiol Biomarkers Prev (2008) 1.14
Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health (2011) 1.13
Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecol Oncol (2009) 1.13
Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort. Gynecol Oncol (2012) 1.13
Mode of delivery and neonatal survival of infants with isolated gastroschisis. Obstet Gynecol (2004) 1.13
Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg (2007) 1.13
Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. J Clin Oncol (2002) 1.12
Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer (2005) 1.12
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol (2008) 1.11
Obtaining DNA from a geographically dispersed cohort of current and former smokers: use of mail-based mouthwash collection and monetary incentives. Nicotine Tob Res (2004) 1.11
Internet cigarette purchasing among ninth-grade students in Western New York. Prev Med (2003) 1.09
Prevalence and correlates of gastroschisis in 15 states, 1995 to 2005. Obstet Gynecol (2013) 1.08